21 February 2018

Back to News

AvantiCell Science is delighted to be one of eight beneficiary companies involved in the European Union Horizon 2020 framework programme - EuroNeuroTrophin (


This is a European training network for the discovery of small molecule neurotrophin mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation.


Read the EuroNeuroTrophin press release here.